PharmaTimes April 22, 2022
Researchers were able to detect specific combinations of genetic alterations which may hold key to the growth of cancers
UK scientists are currently analysing the complete genetic make-up – or whole genome sequence – of tumours from about 12,000 patients in the country.
The team says that the unprecedented amount of data allowed them to discover new patterns in the DNA of cancer, hinting at causes that are not yet understood. They add that the genetic clues are likely to help improve diagnosis and treatment.
The research is published in Science and led by the University of Cambridge. The research team analysed anonymised DNA data provided by the 100,000 Genomes Project – a nationwide initiative to sequence the whole genomes...